We are live on ! Find out more
SBL

Sargent Bickham Lagudis Portfolio holdings

AUM $1.22B
1-Year Est. Return 14.94%
This Fund
S&P 500
This Quarter Est. Return
-14.95%
1 Year Est. Return
-14.94%
3 Year Est. Return
+19.11%
5 Year Est. Return
+40.37%
10 Year Est. Return
AUM
$777M
AUM Growth
-$125M
Cap. Flow
-$383M
Cap. Flow %
-49.24%
Top 10 Hldgs %
43.76%
Holding
1,023
New
122
Increased
255
Reduced
162
Closed
209

Sector Composition

Rank Sector Weight
1 Healthcare 6.16%
2 Technology 5.43%
3 Financials 4.75%
4 Consumer Discretionary 4.04%
5 Communication Services 2.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
76
Johnson & Johnson
JNJ
$618B
$2.13M 0.27%
16,265
+3,085
+23% +$438K
SCHM icon
77
Schwab US Mid-Cap ETF
SCHM
$14.5B
$2.12M 0.27%
150,927
+41,475
+38% +$759K
VWO icon
78
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$2.1M 0.27%
62,645
+50,820
+430% +$2.07M
SBUX icon
79
Starbucks
SBUX
$120B
$2.1M 0.27%
31,962
+1,605
+5% +$130K
BSCN
80
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$2.07M 0.27%
99,816
+810
+0.8% +$17.1K
RGLD icon
81
Royal Gold
RGLD
$16.8B
$2.06M 0.27%
23,532
-613
-3% -$63.3K
LMBS icon
82
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.35B
$2.06M 0.26%
40,327
-25,082
-38% -$1.3M
SCHD icon
83
Schwab US Dividend Equity ETF
SCHD
$103B
$1.86M 0.24%
124,371
-34,530
-22% -$620K
SCHA icon
84
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$1.82M 0.23%
141,560
-54,004
-28% -$918K
ABBV icon
85
AbbVie
ABBV
$443B
$1.79M 0.23%
23,436
+2,405
+11% +$205K
MRK icon
86
Merck
MRK
$322B
$1.72M 0.22%
23,385
+517
+2% +$40.6K
GOOG icon
87
Alphabet (Google) Class C
GOOG
$4.36T
$1.71M 0.22%
29,440
+2,720
+10% +$185K
IYW icon
88
iShares US Technology ETF
IYW
$23.6B
$1.69M 0.22%
33,156
+352
+1% +$20.4K
BSCL
89
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
$1.68M 0.22%
80,253
CNC icon
90
Centene
CNC
$30.7B
$1.63M 0.21%
27,504
+6,419
+30% +$389K
BNDX icon
91
Vanguard Total International Bond ETF
BNDX
$81.9B
$1.61M 0.21%
28,689
+24,657
+612% +$1.41M
ACWX icon
92
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$1.61M 0.21%
42,774
-65,384
-60% -$2.94M
CI icon
93
Cigna
CI
$73.7B
$1.59M 0.2%
8,952
+2,565
+40% +$498K
BSCK
94
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
$1.43M 0.18%
68,276
CIEN icon
95
Ciena
CIEN
$53.4B
$1.43M 0.18%
+35,823
New +$1.47M
CSCO icon
96
Cisco
CSCO
$457B
$1.42M 0.18%
36,194
+21,928
+154% +$962K
INFO
97
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.35M 0.17%
22,465
+21,474
+2,167% +$1.55M
APTV icon
98
Aptiv
APTV
$12B
$1.33M 0.17%
26,943
+2,158
+9% +$169K
VFC icon
99
VF Corp
VFC
$5.63B
$1.32M 0.17%
24,412
+61
+0.3% +$4.75K
TMO icon
100
Thermo Fisher Scientific
TMO
$213B
$1.31M 0.17%
4,616
+4,132
+854% +$1.3M

Similar funds

Sargent Bickham Lagudis's Q1 2020 Portfolio in Review

As of Q1 2020, Sargent Bickham Lagudis held 1,023 positions worth $777M, down 14% from $902M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sargent Bickham Lagudis withdrew a net $383M in Q1 2020, closing 209 positions and reducing 162 holdings. Its most notable exit was Invesco Senior Loan ETF, an estimated $2.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.2% of assets, up from 4.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Sargent Bickham Lagudis opened a new position in Ciena worth $1.43M.

  • Sargent Bickham Lagudis's largest Q1 2020 buy was Ciena: 35,823 shares worth $1.43M.
  • Sargent Bickham Lagudis added most to Pfizer in Q1 2020, an estimated $10.5M increase.
  • Sargent Bickham Lagudis's biggest Q1 2020 reduction was Berkshire Hathaway Class A, cutting an estimated $414M.
  • Sargent Bickham Lagudis fully exited Invesco Senior Loan ETF in Q1 2020, selling an estimated $2.69M.
  • Sargent Bickham Lagudis's ten largest holdings make up 44% of its $777M portfolio in Q1 2020.
  • Sargent Bickham Lagudis opened 122 new positions and closed 209 in Q1 2020.
  • Sargent Bickham Lagudis's portfolio value fell 14% quarter-over-quarter to $777M.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2020, filed 7 Sep 2021.